• Chief legal counsel to companies across diagnostic testing, health and medical software, devices, virtual health, and remote patient monitoring
  • Law professor and author of business law books
  • Helped build and sell four companies to publicly traded acquirors, plus one IPO

Paul Swegle, JD
Chief Legal Officer

Paul is a UW Law graduate and has served as general counsel and chief legal officer to 20+ companies across many industries, including health and medical software and devices, virtual health/telehealth, and remote patient monitoring. He has helped build and sell four companies to publicly traded acquirors, including one to Abbott Laboratories in 2020. He also helped take a company public in 2020. Paul began his legal career with the Securities and Exchange Commission and also served as a Special Assistant United States Attorney. He has been a leader in the Washington State Bar Association, serving twice as Chair of the Corporate Counsel Section and for three years on the Bar’s governing body, the Board of Governors. Paul’s books, Startup Law and Fundraising and Contract Drafting and Negotiation, are used in law and MBA schools around the world, and he gives frequent talks and interviews. FintechTV recently interviewed Paul on the floor of the New York Stock Exchange about SPAC IPOs. Paul is an adjunct law professor at Seattle U School of Law and Gonzaga School of Law.

< back

Urology San Antonio

What We Provided:

  • Remote Lab in office urology PCR lab Lab equipment & proprietary validation
  • Training and technical support
  • Reagents and consumables on a recurring basis
  • Lab reports using our proprietary software

How Molecular has helped Urology San Antonio achieve their goals:

  • Lowered costs to lab & patient
  • High- quality patient care
  • Quicker turn around times
  • More accurate lab results

Alan Winkler, Executive Director

New service lines like PCR allow us to better serve the clinical needs of our patients; however, new opportunities come with new challenges.
It has been wonderful to have the expertise of MTL to put in place appropriate clinical resources to operate an efficient, financially-viable PCR lab. Autonomy with expert insight. It’s the perfect combination.

Interested In partnering with Molecular Testing Labs?

Let us Empower you.